Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05538741
Other study ID # RMZ_bolcon_old
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 15, 2023
Est. completion date December 31, 2023

Study information

Verified date May 2023
Source Kangbuk Samsung Hospital
Contact Eunah Cho, PhD
Phone 82-2-2001-4657
Email mintflavored@naver.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Even though remimazolam is known to be safely administered without hemodynamic instability, hypotension is the one of the common side effects of remimazolam. Because elderly patients are susceptible to hypotension due to old age, multimodality, and multiple medications, hypotension can be harmful in elderly patients. Remimazolam can be administered either bolus or continuous for anesthetic induction. In our study the investigators aimed to compare the incidence of hypotension after anesthetic induction using remimazolam by bolus injection and continuous infusion in elderly patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 66
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - Elderly patients with age over 60 years old - scheduled for elective surgery under general anesthesia - American Society of Anesthesiology Physical Status I-III Exclusion Criteria: - Arrhythmia - Liver dysfunction - Kidney dysfunction - Uncontrolled hypertension - Uncontrolled diabetes mellitus - Allergic to benzodiazepines - Heart failure - Drug intoxication - Alcoholics - Cognitive dysfunction - Unable to understand and consent voluntarily

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Bolus of remimazolam
0.19-0.25 mg/kg for 60-80 years old 0.14-0.19 mg/kg for >80 years old
Continuous infusion of remimazolam
12 mg/kg/hr until loss of consciousness

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Kangbuk Samsung Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of hypotension Systolic blood pressure < 90 mmHg 10 minutes after intubation
Secondary The incidence of bradycardia Heart rate < 40 beats per minute 10 minutes after intubation
Secondary Number of participants with use of any vasopressors Use of ephedrine, phenylephrine 10 minutes after intubation
Secondary Lowest systolic blood pressure The lowest systolic blood pressure measured within10 minutes after intubation 10 minutes after intubation
Secondary Time to loss of consciousness Time to loss of consciousness. Loss of consciousness is assessed by the loss of response to shoulder shaking. 10 minutes after intubation
Secondary Total remimazolam used for anesthetic induction Sum of remimazolam used during anesthetic induction 10 minutes after intubation
See also
  Status Clinical Trial Phase
Completed NCT04062994 - A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
Active, not recruiting NCT02016599 - Effects of Transitional Circulation in ELBW Infants
Recruiting NCT05836610 - Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates Phase 4
Completed NCT02907931 - Carotid Doppler Ultrasound for the Measurement of Intravascular Volume Status N/A
Completed NCT03215797 - Phenylephrine or Norepinephrine for a Better Hemodynamic Stability Phase 3
Suspended NCT02315937 - Hemodynamic Assessment During Spinal Anesthesia Using Transthoracic Echocardiography' N/A
Recruiting NCT02532270 - Detecting Hypotension By Continuous Non-invasive Arterial Pressure Monitoring N/A
Completed NCT02802683 - Hemodynamic Impact of Hyperbaric Versus Isobaric for Spinal Anesthesia During Cesarean Delivery Phase 4
Completed NCT02437799 - Dicrotic Notch and Hypotension at Caesarean Under Spinal Anaesthesia N/A
Completed NCT02146898 - The Severity Of Hypotension Comparing Three Positions During Spinal Anesthesia For Cesarean Delivery N/A
Completed NCT01930227 - Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hypotension After Spinal Anesthesia in Parturients N/A
Not yet recruiting NCT01941472 - Transcutaneous pO2, Transcutaneous pCO2 and Central Venous pO2 Variations to Predict Fluid Responsiveness N/A
Recruiting NCT01434251 - Treatment of Hypotension of Prematurity (TOHOP) N/A
Completed NCT01592669 - Passive Leg Raising Attenuates and Delays Tourniquet Deflation-induced Hypotension and Tachycardia N/A
Withdrawn NCT01183741 - Accuracy of Non-Invasive Blood Pressure Measurement in Adults Phase 3
Completed NCT00991627 - Different Approaches to Maternal Hypotension During Cesarean Section Phase 4
Withdrawn NCT00750516 - Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet
Completed NCT00115726 - Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure Phase 4
Recruiting NCT05513066 - Management Arterial Hypotension During Planned Caesarean Section, Intravenous Ephedrine/Phenylephrine Mixture Versus Intravenous Baby Noradrenaline
Completed NCT04089644 - Manual vs Closed-loop Control of Mean Arterial Pressure N/A